BCAT Launches Transferable Rights Offering at Up to 1.5% Discount to NAV
BCAT sits 16% above its 52-week low of $13.73.
Summary
BCAT announced a transferable rights offering with a record date of September 25, 2026 and expiration October 21, 2026. Shareholders get one right per share; five rights buy one new share at a price between 98.5% of NAV and $0.01 below NAV.
Key Events · Financing and Capital Events · BCAT
-
Rights Offering Terms Announced
Record date September 25, 2026; expiration October 21, 2026. One right per share; five rights required to purchase one new share.
-
Subscription Price Formula
Price equals 95% of the 5-day average market price, capped at $0.01 below NAV and floored at 98.5% of NAV per share on the expiration date.
-
Over-Subscription Privilege
Record date shareholders who fully exercise their rights may subscribe for additional shares not taken up by others, subject to pro rata allocation if oversubscribed.
-
Rights Trading on NYSE
Rights expected to trade under symbol 'BCAT RT' until October 20, 2026, one trading day before expiration.
Analysis · BCAT · Unknown
BlackRock Capital Allocation Term Trust is issuing transferable rights to existing shareholders, allowing them to buy new shares at a discount to NAV. The subscription price will be 95% of the 5-day average market price, but no lower than 98.5% of NAV and no higher than $0.01 below NAV. This structure lets the fund raise capital while giving current holders a chance to maintain their ownership stake or sell the rights. The offering is dilutive to non-participating shareholders, but the discount is modest and the adviser is covering all expenses, which reduces the cost to the fund. The fund is trading near its 52-week high, which may make the rights less attractive if the market price stays above the subscription formula.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30% of the 1963 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.14%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BCAT was trading at $15.98 on NYSE in the Unknown sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $13.73 to $16.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.